« Previous
Next »
The Journal of Pediatrics
Volume 148, Issue 5
, Pages 623-627.e3
, May 2006
Rituximab therapy for childhood-onset systemic lupus erythematosus
References
- Initial presentation of childhood-onset systemic lupus erythematosus (a French multicenter study) . J Pediatr . 2005;146:648–653
- Immunological and clinical differencies between juvenile and adult onset of systemic lupus erythematosus . Lupus . 1999;8:287–292
-
.
Treatment options for juvenile-onset systemic lupus erythematosus
.
Pediatr Drugs
. 2002;4:241–256
-
Lipsky PE. Systemic lupus erythematosus : an autoimmune disease of B cell hyperactivity. Nat Immunol 200;2:764-6.
-
.
B cell abnormalities in systemic lupus erythematosus
.
Arthritis Res Ther
. 2003;5(suppl 4):S22–S27
- . A novel mouse with B cells but lacking serum antibody reveals an antibody-indepedent role of B cells in murine lupus . J Exp Med . 1999;189:1639–1648
- . Treating human autoimmune disease by depleting B cells . Ann Rheum Dis . 2002;61:863–866
- . Anti-CD20 therapy in systemic lupus erythematosus (a step closer to the clinic) . Arthritis Rheum . 2005;52:371–377
- . Rituximab (mechanisms and applications) . Br J Cancer . 2001;85:1619–1623
- Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand (an open-label trial) . Arthritis Rheum . 2005;52:501–513
- B cell depletion as a novel treatment for systemic lupus erythematosus (a phase I/II dose-escalation trial of rituximab) . Arthritis Rheum . 2004;50:2580–2589
- . An open study of B lymphocyte depletion in systemic lupus erythematosus . Arthritis Rheum . 2002;46:2673–2677
- . B-cell depletion in the treatment of patients with systemic lupus erythematosus (a longitudinal analysis of 24 patients) . Rheumatology (Oxford) . 2005;44:1542–1545
- . Rituximab anti-B-cell therapy in systemic lupus erythematosus (pointing to the future) . Curr Opin Rheumatol . 2005;17:550–557
- The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus . Arthritis Rheum . 2003;48:455–459
- Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus (association with clinical symptoms) . Ann Rheum Dis . 2002;61:786–792
- The classification of glomerulonephritis in systemic lupus erythematosus revisited . J Am Soc Nephrol . 2004;15:241–250
- Rituximab for the treatment of refractory autoimmune hemolytic anemia in children . Blood . 2003;101:3857–3861
- . Treatment of childhood autoimmune haemolytic anemia with rituximab . Lancet . 2001;358:1511–1513
- . Chronic immune thrombocytopenic purpura in children (assessment of rituximab treatment) . J Pediatr . 2005;146:217–221
- . Successful treatment of refractory myasthenia gravis using rituximab (a pediatric case report) . J Pediatr . 2003;143:674–677
- Rituximab therapy for multisystem autoimmune diseases in pediatric patient . J Pediatr . 2003;143:598–604
-
.
Anti-CD20 monoclonal antibody (rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus
.
Br J Hematol
. 2002;116:465–467
-
Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus
.
Rheumatology
. 2004;43:244
- B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus . Arthritis Rheum . 2005;52:3168–3174
- . Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression . Pediatr Nephrol . 2005;20:811–813
- . Effective B cell depletion with Rituximab in the treatment of autoimmune diseases . Immunobiology . 2002;206:519–527
- Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases . Ann Rheum Dis . 2005;64:913–920
- Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy documented failure to respons to cyclophosphamide alone . Scand J Rheumatol . 2004;33:423–427
- . Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy . Am J Hematol . 2005;78:127–129
- . Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy . Lupus . 2003;12:779–782
-
.
Sustained response to rituximab of autoimmune haemolytic anemia associated with antiphospholipid syndrome
.
Haematologica
. 2004;84:ECR34
-
.
Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren syndrome
.
Rheumatology
. 2004;43:1310–1311
-
.
Targeting B cells for the treatment of rheumatoid arthritis
.
Arthritis Res Ther
. 2003;5:S7–S11
- Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus . Arthritis Rheum . 2003;48:1332–1342
- . Rituximab therapy and autoimmune disorders (prospects for anti-B cell therapy) . Arthritis Rheum . 2003;48:1484–1492
- . An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab . Blood . 2003;101:1071–1079
- . Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus . Arthritis Rheum . 2004;50:3580–3590
Supported by a grant from the Association française pour le syndrome d’Evans.
PII: S0022-3476(06)00069-2
doi: 10.1016/j.jpeds.2006.01.041
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Pediatrics
Volume 148, Issue 5
, Pages 623-627.e3
, May 2006
